Advertisement

Conquer Cancer Foundation


November 10, 2018

Advertisement
Get Permission

Advertisement

Advertisement



Jan
26
Today In Oncology
Addition of Olaparib to Bevacizumab Maintenance in Patients With Advanced Ovarian Cancer Responding to First-Line Therapy
Everolimus/Octreotide Shows Antitumor Activity in Recurrent Meningioma
Higher Concentration of Fusobacterium nucleatum Found in Colorectal Tumors in Patients Younger Than 45
Cancer Incidence in General WTC Responders to the September 11 Attacks
Price Transparency and Variation for Prostate Cancer Radiation Therapy
View More 
Advertisement
Most Read Stories
Mixed Results With Weekly Nab-paclitaxel, Denosumab in Primary Breast Cancer
Brentuximab Vedotin Plus Nivolumab in Hodgkin Lymphoma
Does Proton Pump Inhibitor Use Affect Cognition in Breast Cancer Survivors?
Entrectinib in Advanced ROS1 Fusion–Positive NSCLC
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
View More 
Most Viewed Videos
Francesca Battaglin, MD, on Colorectal Cancer: Using Genetic Variants to Predict Treatment Efficacy
Luca Gianni, MD, on the Neoadjuvant Treatment of Triple-Negative Breast Cancer
Nicoletta Colombo, MD, on Lenvatinib/Pembrolizumab for Advanced Endometrial Cancer
Rashmi K. Murthy, MD, on HER2-Positive Metastatic Breast Cancer: HER2CLIMB Trial of Tucatinib, Capecitabine, and Trastuzumab
Ian E. Krop, MD, PhD, on Trastuzumab Deruxtecan for Patients With Previously Treated, HER2-Positive Metastatic Breast Cancer
View More 
© 2020 HSP News Service, L.L.C.